Is TMS effective for long COVID?

TMS for Long COVID

FDA Clearance Status

TMS is FDA-cleared for major depressive disorder (2008) and OCD (2018). Research continues for other conditions.

Current Evidence

Clinical trials have investigated TMS for long COVID, with varying results. Effectiveness depends on: - Specific brain targets used - Treatment protocols and parameters - Patient selection criteria - Combination with other therapies

Treatment Considerations

If you're considering TMS for long COVID, consult with a psychiatrist experienced in neuromodulation therapies. Insurance coverage may vary for off-label uses.

Research & Clinical Trials

Ongoing studies continue to explore TMS applications for long COVID. Check clinicaltrials.gov for current research opportunities.